APO Research
Talk to an analyst

APO RESEARCH · REPORT

ALK Inhibitors

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global ALK Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025186 pages

Choose your research edition.

Industry ResearchALK Inhibitors Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal ALK Inhibitors Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal ALK Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal ALK Inhibitors Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal ALK Inhibitors Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global ALK Inhibitors market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for ALK Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for ALK Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for ALK Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for ALK Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of ALK Inhibitors include Takeda Pharmaceuticals, Wanbang Biopharmaceuticals, Qilu Pharmaceutical, Novartis, Roche, Jiangsu Aosaikang Pharmaceutical, Pfizer, Betta Pharmaceuticals and Natco Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global ALK Inhibitors market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of ALK Inhibitors and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents ALK Inhibitors sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the ALK Inhibitors market size, projected growth trends, production technologies, key applications, and end-use industries.

ALK Inhibitors Segment by Company

Takeda Pharmaceuticals

Wanbang Biopharmaceuticals

Qilu Pharmaceutical

Novartis

Roche

Jiangsu Aosaikang Pharmaceutical

Pfizer

Betta Pharmaceuticals

Natco Pharma

ALK Inhibitors Segment by Type

Alectinib

Brigatinib

Ensartinib

Crizotinib

Lorlatinib

Ceritinib

Iruplinalkib

Other

ALK Inhibitors Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

ALK Inhibitors Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ALK Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of ALK Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ALK Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the ALK Inhibitors market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of ALK Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of ALK Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of ALK Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. ALK Inhibitors Industry Trends Table 2. ALK Inhibitors Industry Drivers Table 3. ALK Inhibitors Industry Opportunities and Challenges Table 4. ALK Inhibitors Industry Restraints Table 5. Global ALK Inhibitors Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global ALK Inhibitors Revenue Market Share by Manufacturers (2021-2026) Table 7. Global ALK Inhibitors Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global ALK Inhibitors Sales Market Share by Manufacturers Table 9. Global ALK Inhibitors Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global ALK Inhibitors Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global ALK Inhibitors Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global ALK Inhibitors Manufacturers, Product Type & Application Table 13. Global ALK Inhibitors Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global ALK Inhibitors by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Alectinib Table 17. Major Manufacturers of Brigatinib Table 18. Major Manufacturers of Ensartinib Table 19. Major Manufacturers of Crizotinib Table 20. Major Manufacturers of Lorlatinib Table 21. Major Manufacturers of Ceritinib Table 22. Major Manufacturers of Iruplinalkib Table 23. Major Manufacturers of Other Table 24. Global ALK Inhibitors Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global ALK Inhibitors Sales by Type (2021-2026) & (K Units) Table 26. Global ALK Inhibitors Sales by Type (2027-2032) & (K Units) Table 27. Global ALK Inhibitors Sales Market Share by Type (2021-2026) Table 28. Global ALK Inhibitors Sales Market Share by Type (2027-2032) Table 29. Global ALK Inhibitors Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 30. Global ALK Inhibitors Revenue by Type (2021-2026) & (K Units) Table 31. Global ALK Inhibitors Revenue by Type (2027-2032) & (K Units) Table 32. Global ALK Inhibitors Revenue Market Share by Type (2021-2026) Table 33. Global ALK Inhibitors Revenue Market Share by Type (2027-2032) Table 34. Major Manufacturers of Hospital and Clinic Table 35. Major Manufacturers of Retail Pharmacies Table 36. Major Manufacturers of Other Table 37. Global ALK Inhibitors Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global ALK Inhibitors Sales by Application (2021-2026) & (K Units) Table 39. Global ALK Inhibitors Sales by Application (2027-2032) & (K Units) Table 40. Global ALK Inhibitors Sales Market Share by Application (2021-2026) Table 41. Global ALK Inhibitors Sales Market Share by Application (2027-2032) Table 42. Global ALK Inhibitors Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 43. Global ALK Inhibitors Revenue by Application (2021-2026) & (K Units) Table 44. Global ALK Inhibitors Revenue by Application (2027-2032) & (K Units) Table 45. Global ALK Inhibitors Revenue Market Share by Application (2021-2026) Table 46. Global ALK Inhibitors Revenue Market Share by Application (2027-2032) Table 47. Global ALK Inhibitors Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global ALK Inhibitors Sales by Region (2021-2026) & (K Units) Table 49. Global ALK Inhibitors Sales Market Share by Region (2021-2026) Table 50. Global ALK Inhibitors Sales Forecasted by Region (2027-2032) & (K Units) Table 51. Global ALK Inhibitors Sales Forecasted Market Share by Region (2027-2032) Table 52. North America ALK Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. North America ALK Inhibitors Sales by Country (2021-2026) & (K Units) Table 54. North America ALK Inhibitors Sales by Country (2027-2032) & (K Units) Table 55. Europe ALK Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Europe ALK Inhibitors Sales by Country (2021-2026) & (K Units) Table 57. Europe ALK Inhibitors Sales by Country (2027-2032) & (K Units) Table 58. Asia Pacific ALK Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Asia Pacific ALK Inhibitors Sales by Country (2021-2026) & (K Units) Table 60. Asia Pacific ALK Inhibitors Sales by Country (2027-2032) & (K Units) Table 61. South America, Middle East and Africa ALK Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 62. South America, Middle East and Africa ALK Inhibitors Sales by Country (2021-2026) & (K Units) Table 63. South America, Middle East and Africa ALK Inhibitors Sales by Country (2027-2032) & (K Units) Table 64. Global ALK Inhibitors Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global ALK Inhibitors Revenue by Region (2021-2026) & (US$ Million) Table 66. Global ALK Inhibitors Revenue by Region (2027-2032) & (US$ Million) Table 67. Global ALK Inhibitors Revenue Market Share by Region (2021-2026) Table 68. Global ALK Inhibitors Revenue Market Share by Region (2027-2032) Table 69. Takeda Pharmaceuticals Company Information Table 70. Takeda Pharmaceuticals Business Overview Table 71. Takeda Pharmaceuticals ALK Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Takeda Pharmaceuticals ALK Inhibitors Product Portfolio Table 73. Takeda Pharmaceuticals Recent Development Table 74. Wanbang Biopharmaceuticals Company Information Table 75. Wanbang Biopharmaceuticals Business Overview Table 76. Wanbang Biopharmaceuticals ALK Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Wanbang Biopharmaceuticals ALK Inhibitors Product Portfolio Table 78. Wanbang Biopharmaceuticals Recent Development Table 79. Qilu Pharmaceutical Company Information Table 80. Qilu Pharmaceutical Business Overview Table 81. Qilu Pharmaceutical ALK Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Qilu Pharmaceutical ALK Inhibitors Product Portfolio Table 83. Qilu Pharmaceutical Recent Development Table 84. Novartis Company Information Table 85. Novartis Business Overview Table 86. Novartis ALK Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Novartis ALK Inhibitors Product Portfolio Table 88. Novartis Recent Development Table 89. Roche Company Information Table 90. Roche Business Overview Table 91. Roche ALK Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Roche ALK Inhibitors Product Portfolio Table 93. Roche Recent Development Table 94. Jiangsu Aosaikang Pharmaceutical Company Information Table 95. Jiangsu Aosaikang Pharmaceutical Business Overview Table 96. Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Product Portfolio Table 98. Jiangsu Aosaikang Pharmaceutical Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer ALK Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Pfizer ALK Inhibitors Product Portfolio Table 103. Pfizer Recent Development Table 104. Betta Pharmaceuticals Company Information Table 105. Betta Pharmaceuticals Business Overview Table 106. Betta Pharmaceuticals ALK Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Betta Pharmaceuticals ALK Inhibitors Product Portfolio Table 108. Betta Pharmaceuticals Recent Development Table 109. Natco Pharma Company Information Table 110. Natco Pharma Business Overview Table 111. Natco Pharma ALK Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Natco Pharma ALK Inhibitors Product Portfolio Table 113. Natco Pharma Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. ALK Inhibitors Distributors List Table 117. ALK Inhibitors Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. ALK Inhibitors Product Image Figure 2. Global ALK Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global ALK Inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global ALK Inhibitors Sales (2021-2032) & (K Units) Figure 5. Global ALK Inhibitors Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 ALK Inhibitors Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Alectinib Image Figure 9. Brigatinib Image Figure 10. Ensartinib Image Figure 11. Crizotinib Image Figure 12. Lorlatinib Image Figure 13. Ceritinib Image Figure 14. Iruplinalkib Image Figure 15. Other Image Figure 16. Global ALK Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global ALK Inhibitors Sales Market Share 2021 VS 2025 VS 2032 Figure 18. Global ALK Inhibitors Sales Market Share by Type (2021-2032) Figure 19. Global ALK Inhibitors Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global ALK Inhibitors Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global ALK Inhibitors Revenue Market Share by Type (2021-2032) Figure 22. Hospital and Clinic Image Figure 23. Retail Pharmacies Image Figure 24. Other Image Figure 25. Global ALK Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global ALK Inhibitors Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global ALK Inhibitors Sales Market Share by Application (2021-2032) Figure 28. Global ALK Inhibitors Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 29. Global ALK Inhibitors Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global ALK Inhibitors Revenue Market Share by Application (2021-2032) Figure 31. North America ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 32. North America ALK Inhibitors Sales Market Share by Country (2021-2032) Figure 33. U.S. ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Canada ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Mexico ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe ALK Inhibitors Sales Market Share by Country (2021-2032) Figure 38. Germany ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 39. France ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 40. U.K. ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Italy ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Netherlands ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific ALK Inhibitors Sales Market Share by Country (2021-2032) Figure 45. China ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Japan ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Korea ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Southeast Asia ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 49. India ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Australia ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa ALK Inhibitors Sales Market Share by Country (2021-2032) Figure 53. Brazil ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 54. South Africa ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Saudi Arabia ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Turkey ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Argentina ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 58. UAE ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Egypt ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Chile ALK Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Global ALK Inhibitors Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global ALK Inhibitors Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America ALK Inhibitors Revenue (2021-2032) & (US$ Million) Figure 64. North America ALK Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe ALK Inhibitors Revenue (2021-2032) & (US$ Million) Figure 66. Europe ALK Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific ALK Inhibitors Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific ALK Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa ALK Inhibitors Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa ALK Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. ALK Inhibitors Value Chain Figure 72. Manufacturing Cost Structure Figure 73. ALK Inhibitors Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Alectinib
  • Brigatinib
  • Ensartinib
  • Crizotinib
  • Lorlatinib
  • Ceritinib
  • Iruplinalkib
  • Other
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Takeda Pharmaceuticals
  • Wanbang Biopharmaceuticals
  • Qilu Pharmaceutical
  • Novartis
  • Roche
  • Jiangsu Aosaikang Pharmaceutical
  • Pfizer
  • Betta Pharmaceuticals
  • Natco Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global ALK Inhibitors Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global ALK Inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global ALK Inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global ALK Inhibitors Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global ALK Inhibitors Market Dynamics
  1. 2.1 ALK Inhibitors Industry Trends
  2. 2.2 ALK Inhibitors Industry Drivers
  3. 2.3 ALK Inhibitors Industry Opportunities and Challenges
  4. 2.4 ALK Inhibitors Industry Restraints
3 ALK Inhibitors Market by Manufacturers
  1. 3.1 Global ALK Inhibitors Revenue by Manufacturers (2021-2026)
  2. 3.2 Global ALK Inhibitors Sales by Manufacturers (2021-2026)
  3. 3.3 Global ALK Inhibitors Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global ALK Inhibitors Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global ALK Inhibitors Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global ALK Inhibitors Manufacturers, Product Type & Application
  7. 3.7 Global ALK Inhibitors Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global ALK Inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 ALK Inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 ALK Inhibitors Tier 1, Tier 2, and Tier 3
4 ALK Inhibitors Market by Type
  1. 4.1 ALK Inhibitors Type Introduction
  2. 4.1.1 Alectinib
  3. 4.1.2 Brigatinib
  4. 4.1.3 Ensartinib
  5. 4.1.4 Crizotinib
  6. 4.1.5 Lorlatinib
  7. 4.1.6 Ceritinib
  8. 4.1.7 Iruplinalkib
  9. 4.1.8 Other
  10. 4.2 Global ALK Inhibitors Sales by Type
  11. 4.2.1 Global ALK Inhibitors Sales by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global ALK Inhibitors Sales by Type (2021-2032)
  13. 4.2.3 Global ALK Inhibitors Sales Market Share by Type (2021-2032)
  14. 4.3 Global ALK Inhibitors Revenue by Type
  15. 4.3.1 Global ALK Inhibitors Revenue by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global ALK Inhibitors Revenue by Type (2021-2032)
  17. 4.3.3 Global ALK Inhibitors Revenue Market Share by Type (2021-2032)
5 ALK Inhibitors Market by Application
  1. 5.1 ALK Inhibitors Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global ALK Inhibitors Sales by Application
  6. 5.2.1 Global ALK Inhibitors Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global ALK Inhibitors Sales by Application (2021-2032)
  8. 5.2.3 Global ALK Inhibitors Sales Market Share by Application (2021-2032)
  9. 5.3 Global ALK Inhibitors Revenue by Application
  10. 5.3.1 Global ALK Inhibitors Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global ALK Inhibitors Revenue by Application (2021-2032)
  12. 5.3.3 Global ALK Inhibitors Revenue Market Share by Application (2021-2032)
6 Global ALK Inhibitors Sales by Region
  1. 6.1 Global ALK Inhibitors Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global ALK Inhibitors Sales by Region (2021-2032)
  3. 6.2.1 Global ALK Inhibitors Sales by Region (2021-2026)
  4. 6.2.2 Global ALK Inhibitors Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America ALK Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America ALK Inhibitors Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe ALK Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe ALK Inhibitors Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific ALK Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific ALK Inhibitors Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa ALK Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa ALK Inhibitors Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global ALK Inhibitors Revenue by Region
  1. 7.1 Global ALK Inhibitors Revenue by Region
  2. 7.1.1 Global ALK Inhibitors Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global ALK Inhibitors Revenue by Region (2021-2026)
  4. 7.1.3 Global ALK Inhibitors Revenue by Region (2027-2032)
  5. 7.1.4 Global ALK Inhibitors Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America ALK Inhibitors Revenue (2021-2032)
  8. 7.2.2 North America ALK Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe ALK Inhibitors Revenue (2021-2032)
  11. 7.3.2 Europe ALK Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific ALK Inhibitors Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific ALK Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa ALK Inhibitors Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa ALK Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceuticals
  2. 8.1.1 Takeda Pharmaceuticals Company Information
  3. 8.1.2 Takeda Pharmaceuticals Business Overview
  4. 8.1.3 Takeda Pharmaceuticals ALK Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceuticals ALK Inhibitors Product Portfolio
  6. 8.1.5 Takeda Pharmaceuticals Recent Developments
  7. 8.2 Wanbang Biopharmaceuticals
  8. 8.2.1 Wanbang Biopharmaceuticals Company Information
  9. 8.2.2 Wanbang Biopharmaceuticals Business Overview
  10. 8.2.3 Wanbang Biopharmaceuticals ALK Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Wanbang Biopharmaceuticals ALK Inhibitors Product Portfolio
  12. 8.2.5 Wanbang Biopharmaceuticals Recent Developments
  13. 8.3 Qilu Pharmaceutical
  14. 8.3.1 Qilu Pharmaceutical Company Information
  15. 8.3.2 Qilu Pharmaceutical Business Overview
  16. 8.3.3 Qilu Pharmaceutical ALK Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Pharmaceutical ALK Inhibitors Product Portfolio
  18. 8.3.5 Qilu Pharmaceutical Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis ALK Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis ALK Inhibitors Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche ALK Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche ALK Inhibitors Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 Jiangsu Aosaikang Pharmaceutical
  32. 8.6.1 Jiangsu Aosaikang Pharmaceutical Company Information
  33. 8.6.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  34. 8.6.3 Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Aosaikang Pharmaceutical ALK Inhibitors Product Portfolio
  36. 8.6.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer ALK Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer ALK Inhibitors Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Betta Pharmaceuticals
  44. 8.8.1 Betta Pharmaceuticals Company Information
  45. 8.8.2 Betta Pharmaceuticals Business Overview
  46. 8.8.3 Betta Pharmaceuticals ALK Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Betta Pharmaceuticals ALK Inhibitors Product Portfolio
  48. 8.8.5 Betta Pharmaceuticals Recent Developments
  49. 8.9 Natco Pharma
  50. 8.9.1 Natco Pharma Company Information
  51. 8.9.2 Natco Pharma Business Overview
  52. 8.9.3 Natco Pharma ALK Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Natco Pharma ALK Inhibitors Product Portfolio
  54. 8.9.5 Natco Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 ALK Inhibitors Value Chain Analysis
  2. 9.1.1 ALK Inhibitors Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 ALK Inhibitors Production Mode & Process
  6. 9.2 ALK Inhibitors Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 ALK Inhibitors Distributors
  9. 9.2.3 ALK Inhibitors Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst